Pharmaceutical

CEPI and Samsung Biologics partner to boost global vacc...

Samsung Biologics is set to become part of CEPI’s Vaccine Manufacturing Facility...

UP Pharma Conclave 1.0 inaugurated in Lucknow; Gov outl...

CM Yogi Adityanath sets out policy framework, law and order measures, and pharm...

CDSCO approves durvalumab with FLOT for resectable gast...

Approval based on phase III MATTERHORN study supports perioperative use The pos...

Sun Pharma named principal sponsor and health partner o...

Three-year partnership marks Sun Pharma’s first cricket sponsorship The post Su...

Friendshoring: Pharma’s next supply chain bet?

With friendshoring gaining attention in global supply chain conversations, this...

SanegeneBio and Genentech sign $1.5bn global RNAi licen...

The deal grants Genentech exclusive global rights to develop and commercialise t...

Aquestive receives FDA CRL for Anaphylm allergic reacti...

The therapy aims to treat Type I allergic reactions, including anaphylaxis, in p...

SPARC receives Priority Review Voucher associated with ...

Sun Pharma Advanced Research Company (SPARC) announced  that the United States ...

Lupin launches Dasatinib tablets in United States

Lupin announced the launch of Dasatinib tablets, 20 mg, 50 mg, 70 mg, 80 mg, 10...

Express Pharma February 2026

India's Foremost Pharma & Biotech Magazine ~ Friendshoring: Pharma's Next Suppl...

AstraZeneca India receives CDSCO approval for Durvaluma...

AstraZeneca Pharma India, a global, science-led biopharmaceutical company, anno...

CIRM unveils RAPID funding programme for rare diseases

The initiative aims to speed up the development of platform-based genetic therap...

CHMP grants positive opinion for J&J’s Akeega use

The CHMP recommends the use of niraparib and abiraterone acetate with prednisone...

Lupin and TB Alliance collaborate to advance Telacebec ...

Lupin announced a strategic collaboration with TB Alliance, a nonprofit drug de...

Uttar Pradesh gears up to showcase pharma investment op...

The Uttar Pradesh Food Safety and Drug Administration (FSDA) and Invest UP will...

Rx-to-OTC is not a channel shift—it’s a complete busine...

By 2030, what will truly differentiate winning OTC players in India from the re...